Gyorgy Snell to Protein Kinase Inhibitors
This is a "connection" page, showing publications Gyorgy Snell has written about Protein Kinase Inhibitors.
Connection Strength
0.175
-
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability. EMBO Mol Med. 2018 06; 10(6).
Score: 0.089
-
Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitors. Bioorg Med Chem. 2018 02 01; 26(3):647-660.
Score: 0.086